advertisement
Abstract #99031 Published in IGR 22-4
Posterior chamber implantation of a Preserflo Microshunt in a patient with a compromised endothelium
Martinez-de-la-Casa JM; Saenz-Frances F; Morales Fernandez L; García-Feijoo JArchivos de la Sociedad Espanola de Oftalmologia 2022; 97: 161-164
The objective of the present case is to describe a variation in the Preserflo Microshunt surgical technique, placing it in the posterior chamber to minimise the risk of endothelial cell loss in cases with a compromised endothelium. The patient was a 72-year-old pseudophakic woman, with granular dystrophy and a primary diagnosis of open-angle glaucoma presenting with a progressive visual field defect and an IOP of 26 mmHg with maximal medical therapy. The cornea had incipient stromal folds with an endothelial count of 700 cells/mm. A Preserflo Microshunt was implanted in the posterior chamber to minimise the possibility of further damage to the corneal endothelium. Six months after surgery, the implant remains functional. The IOP is 9 mmHg without medications. As far as we know, this is the first Preserflo implanted in the posterior chamber described in the literature.
Departamento de Inmunología, Oftalmología y ORL, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria del Hospital Clínico San-Carlos (IdISSC), Madrid, Spain. Electronic address: jmmartinezcasa@gmail.com.
Full article